|
C6ORF182 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.34774438673458E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.44949657516258E-11 |
| Normal-vs-Stage2 |
2.76029998858007E-09 |
| Normal-vs-Stage3 |
1.48769885299771E-14 |
| Normal-vs-Stage4 |
1.64457336637724E-12 |
| Stage1-vs-Stage2 |
4.999600E-01 |
| Stage1-vs-Stage3 |
8.238200E-02 |
| Stage1-vs-Stage4 |
1.342740E-03 |
| Stage2-vs-Stage3 |
5.893400E-01 |
| Stage2-vs-Stage4 |
5.083800E-02 |
| Stage3-vs-Stage4 |
9.169600E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.34412530789541E-12 |
| Normal-vs-AfricanAmerican |
5.76869999546759E-08 |
| Normal-vs-Asian |
5.53289969396076E-10 |
| Caucasian-vs-AfricanAmerican |
4.569200E-01 |
| Caucasian-vs-Asian |
7.564000E-01 |
| AfricanAmerican-vs-Asian |
6.466600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.44169137633799E-15 |
| Normal-vs-Female |
1.19989573832413E-11 |
| Male-vs-Female |
2.625200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.64657176782157E-12 |
| Normal-vs-Age(41-60Yrs) |
2.22044604925031E-16 |
| Normal-vs-Age(61-80Yrs) |
1.63946634046397E-12 |
| Normal-vs-Age(81-100Yrs) |
3.918100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.337600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.078030E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.515800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.453600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.924000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.552200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.381200E-01 |
| Classical-VS-Follicular |
8.302000E-01 |
| Classical-VS-Other |
9.745800E-01 |
| Classical-VS-Normal |
4.077704840455E-11 |
| Tall-VS-Follicular |
3.487400E-01 |
| Tall-VS-Other |
6.525600E-01 |
| Tall-VS-Normal |
1.165399998726E-08 |
| Follicular-VS-Other |
9.246400E-01 |
| Follicular-VS-Normal |
6.78930245356923E-11 |
| Other-VS-Normal |
3.316900E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.66533453693773E-15 |
| Normal-vs-N1 |
2.22821761042269E-13 |
| N0-vs-N1 |
5.868400E-02 |
|
|
